NO975140D0 - Transdermalt terapeutisk system (TTS) for administrasjon av testosteron - Google Patents

Transdermalt terapeutisk system (TTS) for administrasjon av testosteron

Info

Publication number
NO975140D0
NO975140D0 NO975140A NO975140A NO975140D0 NO 975140 D0 NO975140 D0 NO 975140D0 NO 975140 A NO975140 A NO 975140A NO 975140 A NO975140 A NO 975140A NO 975140 D0 NO975140 D0 NO 975140D0
Authority
NO
Norway
Prior art keywords
testosterone
therapeutic system
tts
administration
transdermal therapeutic
Prior art date
Application number
NO975140A
Other languages
English (en)
Other versions
NO975140L (no
Inventor
Wilfried Fischer
Daniel Bracher
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of NO975140D0 publication Critical patent/NO975140D0/no
Publication of NO975140L publication Critical patent/NO975140L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO975140A 1995-05-10 1997-11-07 Transdermalt terapeutisk system (TTS) for administrasjon av testosteron NO975140L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19517145A DE19517145C2 (de) 1995-05-10 1995-05-10 Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
PCT/EP1996/002013 WO1996035427A1 (de) 1995-05-10 1996-05-10 Transdermales therapeutisches system (tts) zur verabreichung von testosteron

Publications (2)

Publication Number Publication Date
NO975140D0 true NO975140D0 (no) 1997-11-07
NO975140L NO975140L (no) 1997-11-10

Family

ID=7761562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975140A NO975140L (no) 1995-05-10 1997-11-07 Transdermalt terapeutisk system (TTS) for administrasjon av testosteron

Country Status (17)

Country Link
EP (1) EP0825865B1 (no)
JP (1) JPH11504643A (no)
CN (1) CN1183723A (no)
AT (1) ATE208200T1 (no)
AU (1) AU702710B2 (no)
BR (1) BR9608255A (no)
CA (1) CA2220358A1 (no)
CZ (1) CZ287678B6 (no)
DE (2) DE19517145C2 (no)
DK (1) DK0825865T3 (no)
HU (1) HUP9801130A3 (no)
NO (1) NO975140L (no)
NZ (1) NZ308516A (no)
PL (1) PL323145A1 (no)
SK (1) SK149797A3 (no)
WO (1) WO1996035427A1 (no)
ZA (1) ZA963743B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1429697A (en) * 1995-12-29 1997-07-28 Cygnus, Inc. Systems and methods for the transdermal administration of androgenic agents
ATE226816T1 (de) * 1996-07-03 2002-11-15 Alza Corp Vorrichtungen zur arzneistoffabgabe und herstellungsverfahren
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
DE19646050A1 (de) * 1996-11-08 1998-05-14 Labtec Gmbh Transdermales System mit einem speziellen Süßstoff zur Erhöhung der transdermalen Bioverfügbarkeit
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
ES2226394T3 (es) * 1998-05-22 2005-03-16 Novosis Ag Sistemas transdermales que contienen substancia activa que se libera de forma controlada en el tiempo.
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US8173155B2 (en) 2004-06-01 2012-05-08 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
DK1937276T3 (da) 2005-10-12 2013-02-11 Besins Healthcare Luxembourg Forbedret testosterongel og fremgangsmåde til anvendelse deraf
FR2895679B1 (fr) * 2005-12-29 2012-06-08 Pf Medicament Stabilisation de testosterone au sein de dispositifs transdermiques
CN101480399B (zh) * 2008-09-25 2011-10-05 宋博 睾酮在制备治疗弱精子症的药物中的应用
DE102011012712A1 (de) 2011-03-01 2012-09-06 Frank Lehmann-Horn Verwendung von Aldosteron-Rezeptor-Antagonisten zur Behandlung von weiblicher sexueller Dysfunktion

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
MX9202350A (es) * 1991-05-20 1992-11-01 Alza Corp Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
DE69326461T2 (de) * 1992-06-11 2000-05-04 Theratech Inc Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
JP3489831B2 (ja) * 1993-04-20 2004-01-26 ヘクサル・アクチエンゲゼルシャフト 活性成分パッチ
DE4313402A1 (de) * 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermale Wirkstoffzubereitung
US5460820B1 (en) * 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women

Also Published As

Publication number Publication date
EP0825865B1 (de) 2001-11-07
NO975140L (no) 1997-11-10
DE59608150D1 (de) 2001-12-13
DE19517145C2 (de) 2000-02-24
CA2220358A1 (en) 1996-11-14
PL323145A1 (en) 1998-03-16
AU702710B2 (en) 1999-03-04
BR9608255A (pt) 1999-02-02
CZ351297A3 (cs) 1998-03-18
DK0825865T3 (da) 2002-02-18
ATE208200T1 (de) 2001-11-15
JPH11504643A (ja) 1999-04-27
ZA963743B (en) 1996-11-18
EP0825865A1 (de) 1998-03-04
DE19517145C1 (de) 1996-11-28
WO1996035427A1 (de) 1996-11-14
SK149797A3 (en) 1998-05-06
CN1183723A (zh) 1998-06-03
NZ308516A (en) 1999-05-28
HUP9801130A2 (hu) 1998-08-28
HUP9801130A3 (en) 2001-03-28
CZ287678B6 (en) 2001-01-17
AU5805096A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
DE69527509D1 (de) Hydrogelformulierung mit gesteuerter freisetzung
PL324552A1 (en) Plaster for pecutaneous administration of hormones
NL194780B (nl) Oraal therapeutisch systeem voor toediening van een anticonvulsivum.
AU3990797A (en) Sustained release formulation
NO975140D0 (no) Transdermalt terapeutisk system (TTS) for administrasjon av testosteron
HU9203871D0 (en) Pharmaceutical application of certain cistine derivatives
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
TR199700711T1 (xx) Ciltten ge�erek v�cuda giren form�lasyon.
ZA942872B (en) Transdermal therapeutic systems for administering active substances
AU7291996A (en) Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction
NO893909D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
DE69626544T2 (de) Arzneistoffe
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
IL96506A0 (en) Transdermal system for administering pharmaceutical compounds under ph control
ATE211383T1 (de) Topische aciclovir-zubereitung
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
GR1001412B (el) Συν?έσεις χρήσιμες δια την ?εραπευτική αγωγή της ξηρότητος του κόλπου.
NO931208L (no) Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike
UA23119A (uk) Психотропhий засіб

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application